Abacus Life Secures $150M Debt Financing

By Bobby Samwell • Wednesday, December 11 15:17 • Permanent Link

Abacus Life, Inc. (NASDAQ: ABL) has successfully closed a $150 million debt financing facility to support its continued growth. The facility was structured to offer flexible terms, ensuring that Abacus is well positioned to meet its long-term strategic objectives. The financing was arranged and led by Sagard, with Värde Partners holding a significant commitment.

The CEO of Abacus Life, Jay Jackson, stated that the funding provides the company with sufficient capital to meet inventory demand and ensures that there will be no need to raise incremental equity in the foreseeable future. This empowers the company to continue growing its business and strengthen its position as an industry leader.

Elena Plesco, the Chief Capital Officer of Abacus Life, emphasized that the facility provides financial flexibility to continue executing the company's strategic vision. The strong support from new institutional partners at Sagard and Värde reflects confidence in Abacus Life's business model and growth trajectory.

The debt financing facility represents a significant milestone for the company, providing the financial flexibility to continue executing its strategic vision. The strong support from new institutional partners at Sagard and Värde reflects confidence in Abacus Life's business model and growth trajectory.

With nearly $3 billion in assets under management, including recently completed acquisitions, Abacus Life is the only publicly traded global alternative asset manager focused on lifespan-based financial products. The company is expanding its leading expertise in longevity and lifespan into new growth areas, including ABL Wealth and ABL Tech, which leverage data and proprietary algorithms to offer longevity-based wealth management platforms and groundbreaking technology services.

Sagard, a global multi-strategy alternative asset management firm with US$25 billion under management, led the financing, reflecting their commitment to providing innovative credit solutions and collaborating with Abacus Life.

This debt financing facility marks a significant step forward for Abacus Life, providing the resources to strengthen operations, expand offerings, and solidify its position as a market leader in life settlements. Today the company's shares have moved -1.1% to a price of $7.94. For the full picture, make sure to review Abacus Life's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.